# ATROVENT HFA
> **NDA021527** · New Drug Application · Sponsor: BOEHRINGER INGELHEIM · Approved 2004-11-17
## Drug
- **FDA Application Number:** NDA021527
- **Application type:** New Drug Application
- **Brand name:** ATROVENT HFA
- **Generic name:** IPRATROPIUM BROMIDE
- **Active ingredients:** IPRATROPIUM BROMIDE
- **Dosage form:** AEROSOL, METERED
- **Route:** INHALATION
- **Marketing status:** Prescription
- **Sponsor:** BOEHRINGER INGELHEIM
- **Manufacturer:** Boehringer Ingelheim Pharmaceuticals, Inc.
- **First approval:** 2004-11-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021527)
---
*MORVS · CC0 1.0*